Substance / Medication

Testosterone undecanoate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

12 trials linked to this intervention

12
Total Trials
2
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
[Effect and safety of testosterone undecanoate in the treatment of late-onset hypogonadism: a meta-analysis].
Zheng Yi, Shen Xu-bo, Zhou Yuan-zhong et al. · Zhonghua Nan Ke Xue · 2015
PMID: 25898560Meta-Analysis
A Randomized Controlled Trial Comparing Testosterone Enanthate and Testosterone Undecanoate as a Gender Affirming Hormonal Therapy in Trans Males.
Sinju Sankar, Sridhar Subbiah, Sreenivasan Palaniyappan et al. · Clin Endocrinol (Oxf) · 2025
PMID: 40012162RCT
Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism.
Miner Martin, Wang Christina, Kaminetsky Jed et al. · Andrology · 2025
PMID: 39252657RCTFull text (PMC)
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections.
Handelsman David J, Desai Reena, Conway Ann J et al. · Eur J Endocrinol · 2022
PMID: 35000898RCT
[Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism].
DI Hong-Jie, Fan Yao-Fu, Zhang Hui-Feng et al. · Zhonghua Nan Ke Xue · 2017
PMID: 29722943RCT
[Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males].
Mao Jun-Biao, Chen Xiao-Gang, Gui Ding-Wen et al. · Zhonghua Nan Ke Xue · 2017
PMID: 29717839RCT
Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women.
Tungmunsakulchai Reuthairat, Chaikittisilpa Sukanya, Snabboon Thiti et al. · BMC Womens Health · 2015
PMID: 26631095RCTFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Testosterone undecanoate (substance)
SNOMED CT
395900004
UMLS CUI
C0076195

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

4
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.